Daniel L. Menichella

from Wikipedia, the free encyclopedia

Daniel L. Menichella is an American manager.

Menichella received a bachelor's degree in economics from Harvard University in 1981 . At the University of North Carolina at Chapel Hill , he completed another degree in 1990 as a Master of Business Administration .

Menichella replaced the founder Ingmar Hoerr as CEO of CureVac in 2018 . He was replaced by Hoerr on March 11, 2020. As a result, numerous media reported the content of a meeting between Menichella and Donald Trump about the development of a vaccine against SARS-CoV-2 .

Web links

Individual evidence

  1. Change at the top of CureVac curevac.com, May 8, 2018
  2. Change in the board of CureVac: Company founder Ingmar Hoerr succeeds CEO Daniel Menichella curevac.com, from March 11, 2020
  3. USA and Germany in the tug-of-war over vaccines zdf.de, from March 15, 2020
  4. USA and Germany argue about vaccine tagesschau.de, March 15, 2020